Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib vs Imatinib + PegIntron in Newly Diagnosed CML
NCT01227356Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Sep 2004
- Primary completion
- Mar 2009
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in chronic myeloid leukemia (CML), sponsored by Uppsala University. Started Sep 2004; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT01227356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227356.